or Try an Advanced Search...

    Antisense RNA Stocks List

    Symbol Grade Name % Change
    SRPT B Sarepta Therapeutics, Inc. 2.32
    PRAX B Praxis Precision Medicines, Inc. 0.70
    IONS F Ionis Pharmaceuticals, Inc. -2.60
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Dystrophy Huntington's Disease Ionis Rare Diseases Spinal Muscular Atrophy Therapeutic Gene Modulation Acromegaly Alcohol Alport Syndrome Amyloid Amyloidosis Angioedema Apatorsen Biology Biotechnology Cancer Cardiomyopathy Central Nervous System Disorders Cholesterol

    Related ETFs - A few ETFs which own one or more of the above listed Antisense RNA stocks.

    Symbol Grade Name Weight
    PINK C Simplify Health Care ETF 8.61
    IDNA C iShares Genomics Immunology and Healthcare ETF 5.83
    IBRN D iShares Neuroscience and Healthcare ETF 4.65
    BBP D BioShares Biotechnology Products Fund 4.61
    ARKG D ARK Genomic Revolution Multi-Sector ETF 4.52
    View all Antisense RNA ETFs...
    Compare ETFs
    Compare IBRN to ARKG Compare PINK to BBP Compare PINK to IDNA

        Antisense RNA Stocks Recent News

        Date Stock Title
        May 3 SRPT Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
        May 2 SRPT Sarepta Therapeutics to Benefit as Regulatory Review on DMD Therapy Picks Up, Morgan Stanley Says
        May 2 SRPT Sarepta Elevidys accelerated approval criticized by ICER exec
        May 2 SRPT Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
        May 2 SRPT Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
        May 2 PRAX Wall Street Analysts See a 144.74% Upside in Praxis Precision Medicines (PRAX): Can the Stock Really Move This High?
        May 2 SRPT Q1 2024 Sarepta Therapeutics Inc Earnings Call
        May 2 SRPT Sarepta Therapeutics Inc (SRPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
        May 1 SRPT Sarepta Therapeutics (SRPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
        May 1 SRPT Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript
        May 1 SRPT Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript
        May 1 SRPT Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates
        May 1 SRPT Sarepta Therapeutics jumps 5% on Q1 beats
        May 1 SRPT Sarepta Therapeutics Non-GAAP EPS of $0.73 beats by $0.43, revenue of $413.5M beats by $43.02M
        May 1 SRPT Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
        May 1 IONS 4D Molecular Therapeutics, Inc. (FDMT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
        May 1 SRPT 1 Top Growth Stock to Buy and Hold for 10 Years
        Apr 30 SRPT Sarepta Therapeutics Q1 2024 Earnings Preview
        Apr 30 IONS Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
        Apr 30 SRPT Why Sarepta (SRPT) Might Surprise This Earnings Season
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Dystrophy Huntington's Disease Ionis Rare Diseases Spinal Muscular Atrophy Therapeutic Gene Modulation Acromegaly Alcohol Alport Syndrome Amyloid Amyloidosis Angioedema Apatorsen Biology Biotechnology Cancer Cardiomyopathy Central Nervous System Disorders Cholesterol
        Antisense RNA

        Browse All Tags